63189-97-9Relevant articles and documents
HETEROCYCLIC COMPOUNDS AS INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR
-
Page/Page column 126, (2020/09/03)
Disclosed are heterocyclic compounds as inhibitors of FGFR-4 represented by formula (I). Also disclosed is a pharmaceutical composition that includes an inhibitor of FGFR-4. The compounds maybe used to treat diseases mediated with abnormality of FGFR-4 and /or FGF19, such as hepatocellular carcinoma and other forms of cancer.
HETEROCYCLIC KINASE INHIBITORS
-
Page 330, (2010/02/08)
Compounds having the formula (I) are useful for inhibiting protein kinases. Also disclosed are methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
Possible Anthelmintic Agents: Syntheses of Methyl 5(6)-Substituted-benzimidazole-2-carbamates
Akhtar, M. Shamim,Seth, M.,Bhaduri, A. P.
, p. 395 - 399 (2007/10/02)
Syntheses of α-phenyl-propionitrile (2), α-phenyl-acrylonitrile (3), methyl 5(6)-hydroxymethylbenzimidazole-2-carbamate (6), β-(2-methoxycarbonylamino)-5(6)-benzi